The 2025 American Society of Clinical Oncology guideline update redefines the role of sentinel lymph node biopsy (SLNB) in early-stage breast cancer. Building on evidence from major trials, the update...
The latest OVATION-2 trial update, presented at the American Society of Clinical Oncology 2025 annual meeting, shows that adding intraperitoneal IMNN-001 to standard neoadjuvant chemotherapy improved both...
A phase II trial evaluating pembrolizumab plus lenvatinib in clear cell ovarian carcinoma shows promising response rates and 6-month progression-free survival.
A retrospective analysis from Memorial Sloan Kettering links higher patient-reported pain to increased emergency department utilization among individuals newly diagnosed with ovarian cancer. This study was...
Patients with endometriosis face significantly higher risks of postoperative complications when undergoing surgery for stage I endometrial cancer, according to a new study presented at the Society of...
Secretary Robert F. Kennedy Jr. announced that the CDC will no longer recommend the COVID-19 booster vaccine for healthy children and pregnant people. The announcement comes despite previous CDC...
A clinical trial found hysteroscopic resection may improve outcomes for progestin-resistant atypical hyperplasia or grade 1 endometrial cancer in select patients. This study was presented at the Society of...
Patients who underwent laparoscopic hysterectomy alone were more likely to be readmitted within 60 days compared with those who also received sacrocolpopexy.
Virtual reality shows benefits in reducing both pain and anxiety across multiple clinical OBGYN settings, according to the results of a recent systematic review presented at the 2025 ACOG Annual Clinical...
A new analysis of more than 42,000 cases reveals that uterine serous carcinoma is almost exclusively a postmenopausal disease, with less than 2% of cases diagnosed before age 52 — highlighting menopause,...
